Blood Flow Restriction Training in Patients With Lower Extremity Fractures
NCT ID: NCT06496035
Last Updated: 2025-11-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
40 participants
INTERVENTIONAL
2024-11-01
2026-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Blood Flow Restriction Therapy to Optimize Muscle Size and Strength in Recovery From Lower Limb Fractures
NCT07103252
Blood Flow Restriction Therapy Improves Tibial Plateau Fracture Recovery
NCT06589115
Early Standardized Weight Bearing Utilizing Immersion Therapy Following Periarticular Lower Extremity Fractures
NCT01457326
The Role of Blood Flow Restriction Therapy in Postoperative Elderly Patients With Hip Fracture
NCT04809714
Improving Functional Recovery After Hip Fracture
NCT00000436
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Blood flow restriction training
Patients will perform exercises as directed by a Doctor of Physical Therapy with the use of blood flow restriction device
Blood Flow Restriction with low load exercise
Cuff/tourniquet will be applied to proximal leg at hip crease and inflated to 60-80% of limb occlusion pressure to decrease venous blood flow in the limb while performing exercise.
Traditional physical therapy
Patients perform physical therapy exercises guided by a Doctor of Physical Therapy without the use of a blood flow restriction device, as is current standard practice.
Therapeutic Exercise
Exercise performed at appropriate load as guided by physical therapist
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Blood Flow Restriction with low load exercise
Cuff/tourniquet will be applied to proximal leg at hip crease and inflated to 60-80% of limb occlusion pressure to decrease venous blood flow in the limb while performing exercise.
Therapeutic Exercise
Exercise performed at appropriate load as guided by physical therapist
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Ability to begin physical therapy treatment within 2 weeks post-operatively
Exclusion Criteria
* Impaired circulation in the limb
* Active deep vein thrombosis
* Clotting disorders or other elevated risk of embolism
* Sickle cell anemia
* Infection in extremity
* Renal compromise
* Severe uncontrolled hypertension (SBP\>180)
* Lymphedema
* Under age 18
* Pregnancy
* Prisoner
18 Years
100 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Denver Health and Hospital Authority
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Megan E Smith, PT, DPT
Role: PRINCIPAL_INVESTIGATOR
Denver Health
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Denver Health Medical Center
Denver, Colorado, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
24-0894
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.